View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

NextPharma Sponsors the Bioavailability / Bioequivalence, Dissolution and Biowaivers Conference

The Bioavailability / Bioequivalence, Dissolution and Biowaivers Conference is one of the leading conferences for clinical, R&D and regulatory teams working with bioequivalence studies, biowaivers and dissolution testing.

It takes place from 14-15 May at the Continental Zara Hotel, Budapest, Hungary.

Join some 22 regulatory authority and industry experts as they share their experience across key developments and challenges facing the industry.

NextPharma’s Head of Analytical Development Dr Peter Andersch will be speaking on the topic of ‘Best practice: development and validation of discriminatory dissolution methods’.

Register for your delegate pass here: www.informa-ls.com/event/babe14.

NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology